NIPH Clinical Trials Search

Analysis of third-line H. pylori eradication therapy with sitafloxacin

Basic Information

Recruitment status	Complete: follow-up complete
Health condition(s) or Problem(s) studied	Patients with H. pylori eradication failure after first- and second-line therapy
Date of first enrollment	2009/04/01
Target sample size	50
Countries of recruitment	Japan
Study type	Interventional
Intervention(s)	H. pylori eradication therapy with sitafloxacin

Outcome(s)

Primary Outcome	Eradication rate of H. pylori infection by the regimen including sitafloxacin
Secondary Outcome

Key inclusion & exclusion criteria

Age minimum	20years-old
Age maximum	Not applicable
Gender	Male and Female
Include criteria
Exclude criteria	penicillin or quinolone allergy rabeprazole allergy severe liver or renal dysfunction pregnancy or suckling cases with unsuitable determined by doctors